Filing Flows › Skinvisible (SKVI) › Q2 2026 › vs Q1 2026
Skinvisible (SKVI) Q2 2026 vs Q1 2026 (quarter over quarter)
Skinvisible's revenue rose $0 (0%) from $5K in Q1 2026 to $5K in Q2 2026.
Skinvisible, Q2 2026: revenue $5K (0% year over year), net loss $256K, operating cash flow $2K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5K | $5K | $0 | 0% |
| Net loss | $256K | $267K | −$12K | -4% |
| Costs & expenses | $261K | $272K | −$12K | -4% |
| Operating costs | $118K | $131K | −$13K | -10% |
| Interest & other, net | $143K | $141K | $1K | +1% |
| Cost of revenue | $0 | $0 | $0 | — |
| SG&A | $113K | $126K | −$13K | -10% |
| Other operating costs | $5K | $5K | −$11 | -0.2% |
| Operating cash sources | $258K | $266K | −$9K | -3% |
| Depreciation & amortization | $5K | $5K | −$11 | -0.2% |
| Working capital & other | $253K | $261K | −$9K | -3% |
| Net loss absorbed | $256K | $267K | −$12K | -4% |
| Operating cash flow | $2K | −$1K | $3K | — |
Questions
How much did Skinvisible's revenue grow quarter over quarter in Q2 2026?
Skinvisible's revenue rose $0 (0%) from $5K in Q1 2026 to $5K in Q2 2026.